Article info
PDFOriginal research
Pathologic distribution at the time of interval tumor reductive surgery informs personalized surgery for high-grade ovarian cancer
- Correspondence to Dr Shannon Neville Westin, Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; swestin{at}mdanderson.org
Citation
Pathologic distribution at the time of interval tumor reductive surgery informs personalized surgery for high-grade ovarian cancer
Publication history
- Received May 9, 2020
- Revision received September 25, 2020
- Accepted September 30, 2020
- First published October 29, 2020.
Online issue publication
January 08, 2022
Article Versions
- Previous version (1 February 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.